The global Human Papillomavirus (HPV) Vaccine Market, which stood at USD 4.12 billion in 2022, is poised for substantial growth, with forecasts indicating a rise to USD 10.64 billion by 2030. This growth is expected to occur at an impressive compound annual growth rate (CAGR) of 12.6% during the forecast period spanning from 2023 to 2030.Human Papillomavirus (HPV) is one of the most...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)